Celltrion Holdings IPO

South Korea’s top four financial holding firms are estimated to have posted their highest-ever profits in 2024, driven by hefty interest incom...

South Korea’s business-to-business fintech service provider Dozn is planning an initial public offering on the Kosdaq in February for an estim...

Doosan Skoda Power, the Czech-based power plant equipment-making unit of South Korea’s Doosan Enerbility Co., plans to list its shares on the ...

Seoul Guarantee Insurance Co. (SGI) has slashed its target valuation by about 40% in a renewed attempt to go public on the South Korean stock exchan...

Sono Hospitality Group, South Korea’s top resort operator, has vowed to more actively horn in on the business of T'way Air Co., portending a p...

Korea Investment Holdings Co. said on Thursday it was upgraded by three notches from B to A in the MSCI ESG rating this year.The MSCI ESG rating is ...

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

LG CNS Co., an information technology service company, is set to price its initial public offering at the top of its proposed price range to raise 1...

K Bank, a South Korean online lender, said on Wednesday it has again canceled its initial public offering plan amid the languid stock market an...

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

The South Korean fintech industry, which bloomed a decade ago, is poised to take the next step for the coming 10 years after prominent players began...

South Korea’s steel-to-battery materials conglomerate POSCO Group on Monday unveiled a spate of corporate value-up measures, including a highe...

Kurly Inc., South Korea's dawn delivery service market pioneer, has invited a third-party online retailer to sell luxury goods on its platform to bo...

K Bank, a South Korean online lender, is making a fresh attempt to list on the Korean stock market in February 2025 as bitcoin’s record-breaki...

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

LG Electronics Inc. will retire 761,000 shares in 2025, or around 0.5% of its outstanding shares, to increase shareholder returns, the South Korean ...

Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...

Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...

South Korea's government will host an overseas investor relations session to explain the country’s economic conditions and unveil market-boost...

The South Korean won is expected to stage a rebound from its two-year low against the US dollar and hold steady in 2025 after the impeachment of Sou...

South Korea’s biosimilar maker Celltrion Inc. on Friday announced a plan to allot cash and stock dividends simultaneously. The company wi...

South Korea’s GC Biopharma Corp. said on Thursday it acquired the US-based medical-grade source blood plasma company ABO Holding Inc. The...

The National Pension Service (NPS) appears to be stalling on a vote for Doosan Robotics Inc.'s merger with Doosan Bobcat Inc., with major proxy advi...

South Korea’s leading brokerage firm Mirae Asset Securities Co. is poised to sell its stake in LX Pantos Co., adding to expectations of more d...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of allergic asthma an...

LG CNS Co., the information technology service unit of South Korea’s LG Group, plans to acquire a foreign IT company with the proceeds from it...

LG Electronics India Pvt., wholly owned by LG Electronics Inc., has embarked on the process of going public to raise up to 2.6 trillion won ($1.8 bi...

South Korea’s top resort operator Sono International Co. is seeking an initial public offering of its shares on the Korean market next year, r...

South Korea’s biosimilar maker Celltrion Inc. on Wednesday announced a plan to retire about a quarter of its treasury stock worth 563 billion ...

South Korea’s leading biosimilar developer Celltrion Inc. will break ground on its first contract development and manufacturing organization (...